To prevent toxic levels of ROS occurring, cancer cells increase flux through the metabolic pathways that produce NADPH to meet the demands of this molecule; therefore, glioma cells probably show a greater overexpression of the IDH1 gene in CNS WHO grade 3 and 4 gliomas. This evidence concerns the gene IDH1 and cancer.